中文 | English
Return
Total: 74 , 1/8
Show Home Prev Next End page: GO
Author:(Lixin LUO)

1.Sortase:New Target Enzyme in Gram-positive Pathogens

Lixin LUO ; Zhouming SHI

Progress in Biochemistry and Biophysics 2006;0(09):-

2.Clinical observation on the effect of different pharmacotherapy after lacrimal passage plastic laser operation

Qunying LUO ; Lixin SUN ; Decheng XU

Chinese Journal of Practical Nursing 2006;0(06):-

3.Analysis of actual mismatch risk for KIR genes and KIR ligand related genes in kidney transplant recipients

Lixin YU ; Minjie ZHOU ; Min LUO

Chinese Journal of Organ Transplantation 2013;(5):265-268

4.Establishment and Application of Hyperinsulinemic-Euglycemic Clamp Technique in Conscious Rats

Yuehua FENG ; Guanghua LUO ; Lixin CHEN

Tianjin Medical Journal 2014;(1):62-64

5.Association of MICA-STR with leukemia in Hunan Han population

Lixin LI ; Wei TIAN ; Qizhi LUO ; Fan WANG

Chinese Journal of Immunology 1985;0(02):-

6.Optimization of the Extraction Process for Xiaozheng Plaster by Orthogonal Test

Xuewen YUAN ; Hankan PENG ; Lixin YE ; Yuchuan LUO

China Pharmacy 2005;0(15):-

7.Effect of thymosin beta4 on matrix metalloproteinase-2,9 of hypertrophic scar

Zhiqiang FAN ; Lixin LIAO ; Youlai ZHANG ; Fei LUO

Chongqing Medicine 2015;(31):4321-4323,4326

8.Tetrandrine treatment of severe type acute pancreatitis

Ninglei LI ; Yuhong LUO ; Gang XIAO ; Lixin LIU

Journal of Endocrine Surgery 2011;05(1):21-23,26

9.Preoperative treatment and prognosis observation in sensitized recipients of kidney transplantation

Xianlin WANG ; Lixin YU ; Min LUO ; Yun MIAO ; Lulu XIAO

Chinese Journal of Organ Transplantation 2014;35(2):73-76

10.The correlation between human leukocyte antigens-A, B, DRB1 high-resolution alleles and chronic renal failure caused by immunoglobulin-a nephropathy

Lixin YU ; Mingxing ZENG ; Guirong YE ; Min LUO ; Lulu XIAO

Chinese Journal of Organ Transplantation 2015;36(2):73-77

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 74 , 1/8 Show Home Prev Next End page: GO